Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Exponent, Inc.    EXPO

Delayed Quote. Delayed  - 09/23 10:00:00 pm
50.41 USD   -1.31%
09/20 EXPONENT : ABA Life Sciences Legal Summit
09/13 EXPONENT : SFIA Industry Leaders Summit - Navigating Disruptions
09/12 EXPONENT : GasPro Americas
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

EXPONENT EXPONENT : Exponent to Announce Second Quarter 2011 Results

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/11/2011 | 03:35pm CEST

MENLO PARK, CA, July 11, 2011 – Exponent, Inc. (NASDAQ: EXPO), today announced that it will release financial results for the second quarter ended July 1, 2011, immediately following the close of the market on Wednesday, July 20, 2011. The Company will host a corresponding conference call and live webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Paul Johnston, President and Chief Executive Officer, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will discuss the results.

A live webcast of this conference call will be available on the Investor Relations section of the Company’s web site at www.exponent.com/investors. It will also be available via replay beginning two hours after the completion of the call and through Wednesday, July 27, 2011 by dialing 800-406-7325 or 303-590-3030, and entering passcode 4456038#.

About Exponent

Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.

Exponent may be reached at (888) 656-EXPO, info@exponent.com, or www.exponent.com.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPONENT, INC.
09/20 EXPONENT : ABA Life Sciences Legal Summit
09/16 EXPONENT : Ammonium Persulfate; Exemption From the Requirement of a Tolerance
09/13 EXPONENT : SFIA Industry Leaders Summit - Navigating Disruptions
09/12 EXPONENT : GasPro Americas
08/31 EXPONENT, INC. : ex-dividend day
08/05 EXPONENT : Management's Discussion and Analysis of Financial Condition and Resul..
08/01 EXPONENT INC : Change in Directors or Principal Officers, Financial Statements a..
07/31 EXPONENT : Appoints Dr. Catherine Corrigan to President
07/29 Exponent Appoints Dr. Catherine Corrigan to President
07/27 EXPONENT : Source Contribution at Superfund and Other Contaminated Sites - A Leg..
More news
Sector news : Business Support Services - NEC
09/15DJWAL MART STORES : Mart Expands Move to Boycott Visa Cards in Canada -- Update
09/15DJWAL MART STORES : Mart Expands Move to Boycott Visa Cards in Canada
09/15DJWAL MART STORES : Mart Expands Move to Boycott Visa Cards in Canada
09/14DJObama Administration Makes Last-Ditch Push for Trade Vote
09/13DJTeneo, Consulting Firm With Clinton Ties, Eyes $1 Billion IPO
More sector news : Business Support Services - NEC
News from SeekingAlpha
07/20 Midday Gainers / Losers
07/19 Exponent's (EXPO) CEO Paul Johnston on Q2 2016 Results - Earnings Call Transc..
07/19 Exponent declares $0.18 dividend
07/19 Exponent misses by $0.05, misses on revenue
07/18 Notable earnings after Tuesday?s close
Advertisement
Financials ($)
Sales 2016 306 M
EBIT 2016 57,8 M
Net income 2016 -
Debt 2016 -
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 4,28x
Capi. / Sales 2017 4,18x
Capitalization 1 310 M
More Financials
Chart EXPONENT, INC.
Duration : Period :
Exponent, Inc. Technical Analysis Chart | EXPO | US30214U1025 | 4-Traders
Full-screen chart
Technical analysis trends EXPONENT, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Average target price 48,0 $
Spread / Average Target -4,8%
Consensus details
Managers
NameTitle
Paul R. Johnston Chief Executive Officer & Director
Catherine Ford Corrigan President
Michael R. Gaulke Chairman
Richard L. Schlenker Chief Financial Officer, Secretary & Executive VP
Subbaiah V. Malladi Chief Technical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EXPONENT, INC.0.92%1 310
VISA INC6.43%194 861
ACCENTURE PLC8.22%73 585
ECOLAB INC.4.07%34 712
ALLIANCE DATA SYSTEMS ..-21.54%12 700
CINTAS CORPORATION25.38%12 199
More Results